Skip to main content

Advertisement

Log in

Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Transplantation of solid organs, including liver, induces a number of serious complications related to immune incompatibility and requiring long-term use of immunosuppressive drugs. Finding the ways to inducing recipient immunological tolerance to the grafts is a top priority in organ transplantation and immunology. Along with the search for immunosupressive therapy, the development of alternative approaches to induction of immunological tolerance based on cell technologies is now in progress. In this regard, studies of the so-called spontaneous operational tolerance observed in ~20% patients after orthotopic liver transplantation is a promising trend. Understanding of this phenomenon can shed light on the mechanisms of immunological tolerance to allografts and will help to identify specific tolerance biomarkers and cell types with the aptitude for the induction of tolerance to liver allografts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shevchenko OP, Kurabekova RM, Tsiroulnikova OM. Biomarkers of immune tolerance in liver transplantation. Vestn. Tranpslantol. Iskusstv. Organ. 2016;18(3):137-144. Russian.

    Google Scholar 

  2. Yarygin KN, Lupatov AY, Sukhikh GT. Modulation of Immune Responses by Mesenchymal Stromal Cells. Bull. Exp. Biol. Med. 2016;161(4):561-565.

    Article  PubMed  CAS  Google Scholar 

  3. Ashton-Chess J, Giral M, Soulillou JP, Brouard S. Can immune monitoring help to minimize immunosuppression in kidney transplantation?. Transpl. Int. 2009;22(1):110-119.

    Article  PubMed  Google Scholar 

  4. Ballet C, Roussey-Kesler G, Aubin JT, Brouard S, Giral M, Miqueu P, Louis S, van der Werf S, Soulillou JP. Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am. J. Transplant. 2006;6(11):2796-2801.

    Article  PubMed  CAS  Google Scholar 

  5. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, Gonen M, Young JW, DeMatteo RP. Human liver dendritic cells promote T cell hyporesponsiveness. J. Immunol. 2009;182(4):1901-1911.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Behnam Sani K, Sawitzki B. Immune monitoring as prerequisite for transplantation tolerance trials. Clin. Exp. Immunol. 2017;189(2):158-170.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P. The liver: a special case in transplantation tolerance. Semin. Liver Dis. 2007;27(2):194-213.

    Article  PubMed  CAS  Google Scholar 

  8. Benseler V, Warren A, Vo M, Holz LE, Tay SS, Le Couteur DG, Breen E, Allison A. C, van Rooijen N, McGuffog C, Schlitt HJ, Bowen DG, McCaughan GW, Bertolino P. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc. Natl Acad. Sci. USA. 2011;108(40):16,735-16,740.

    Article  Google Scholar 

  9. Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur. J. Immunol. 1998;28(1):221-236.

    Article  PubMed  CAS  Google Scholar 

  10. Boardman DA, Philippeos C, Fruhwirth GO, Ibrahim MA, Hannen RF, Cooper D, Marelli-Berg FM, Watt FM, Lechler RI, Maher J, Smyth LA, Lombardi G. Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection. Am. J. Transplant. 2017;17(4):931-943.

    Article  PubMed  CAS  Google Scholar 

  11. Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, Manzia TM, Angelico R, Swinkels DW, Tjalsma H, López M, Abraldes JG, Bonaccorsi-Riani E, Jaeckel E, Taubert R, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J. Clin. Invest. 2012;122(1):368-382.

    Article  PubMed  CAS  Google Scholar 

  12. Breous E, Somanathan S, Vandenberghe LH, Wilson JM. Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology. 2009;50(2):612-621.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Brouard S, Pallier A, Renaudin K, Foucher Y, Danger R, Devys A, Cesbron A, Guillot-Guegen C, Ashton-Chess J, Le Roux S, Harb J, Roussey G, Subra JF, Villemain F, Legendre C, Bemelman FJ, Orlando G, Garnier A, Jambon H, Le Monies De Sagazan H, Braun L, Noël C, Pillebout E, Moal MC, Cantarell C, Hoitsma A, Ranbant M, Testa A, Soulillou JP, Giral M. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am. J. Transplant. 2012;12(12):3296-3307.

    Article  PubMed  CAS  Google Scholar 

  14. Brunet M, Shipkova M, van Gelder T, Wieland E, Sommerer C, Budde K, Haufroid V, Christians U, López-Hoyos M, Barten MJ, Bergan S, Picard N, Millán López O, Marquet P, Hesselink DA, Noceti O, Pawinski T, Wallemacq P, Oellerich M. Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation. Ther. Drug Monit. 2016;38(Suppl. 1):S1-S20.

    Article  PubMed  Google Scholar 

  15. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, Davies DA. Induction of immunological tolerance by porcine liver allografts. Nature. 1969;223:472-476.

    Article  PubMed  CAS  Google Scholar 

  16. Chai JG, Xue SA, Coe D, Addey C, Bartok I, Scott D, Simpson E, Stauss HJ, Hori S, Sakaguchi S, Dyson J. Regulatory T cells, derived from naïve CD4+CD25— T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation. 2005;79(10):1310-1316.

    Article  PubMed  CAS  Google Scholar 

  17. Chen Y, Liu Z, Liang S, Luan X, Long F, Chen J, Peng Y, Yan L, Gong J. Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats. Liver Transpl. 2008;14(6):823-836.

    Article  PubMed  Google Scholar 

  18. Chesneau M, Michel L, Dugast E, Chenouard A, Baron D, Pallier A, Durand J, Braza F, Guerif P, Laplaud D. A, Soulillou JP, Giral M, Degauque N, Chiffoleau E, Brouard S. Tolerant kidney transplant patients produce B cells with regulatory properties. J. Am. Soc. Nephrol. 2015;26(10):2588-2598.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, Lu L, Qian S. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011;53(3):1007-1019.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol. Rev. 2006;213:101-118.

    Article  PubMed  Google Scholar 

  21. Daniele N, Scerpa MC, Landi F, Caniglia M, Miele MJ, Locatelli F, Isacchi G, Zinno F. T (reg) cells: collection, processing, storage and clinical use. Pathol. Res. Pract. 2011;207(4):209-215.

    Article  PubMed  CAS  Google Scholar 

  22. Detry O, Vandermeulen M, Delbouille MH, Somja J, Bletard N, Briquet A, Lechanteur C, Giet O, Baudoux E, Hannon M, Baron F, Beguin Y. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. J. Hepatol. 2017;67(1):47-55.

    Article  PubMed  Google Scholar 

  23. Diehl L, Schurich A, Grochtmann R, Hegenbarth S, Chen L, Knolle PA. Tolerogenic maturation of liver sinusoidalendothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology. 2008;47(1):296-305.

    Article  PubMed  CAS  Google Scholar 

  24. Doherty DG. Immunity, tolerance and autoimmunity in the liver: A comprehensive review. J. Autoimmun. 2016;66:60-75.

    Article  PubMed  CAS  Google Scholar 

  25. Dugast E, Chesneau M, Soulillou JP, Brouard S. Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients. Immunol. Rev. 2014;258(1):208-217.

    Article  PubMed  Google Scholar 

  26. EASL clinical practice guidelines: liver transplantation. J. Hepatol. 2016;64(2):433-485.

  27. Girmanova E, Hruba P, Viklicky O. Circulating biomarkers of tolerance. Transplant. Rev. 2015;29(2):68-72.

    Article  Google Scholar 

  28. Gorczynski RM, Holmes W. Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences. Immunol. Lett. 1991;27(2):163-171.

    Article  PubMed  CAS  Google Scholar 

  29. Goss JA, Nakafusa Y, Flye MW. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. Ann. Surg. 1992;216(4):409-414.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Grant CR, Liberal R. Liver immunology: How to reconcile tolerance with autoimmunity. Clin. Res. Hepatol. Gastroenterol. 2017;41(1):6-16.

    Article  PubMed  CAS  Google Scholar 

  31. Hartleif S, Schumm M, Döring M, Mezger M, Lang P, Dahlke MH, Riethmüller J, Königsrainer A, Handgretinger R, Nadalin S, Sturm E. Safety and tolerance of donor-derived mesenchymal stem cells in pediatric living-donor liver transplantation: The MYSTEP1 Study. Stem Cells Int. 2017;2017. ID 2352954. doi: https://doi.org/10.1155/2017/2352954.

  32. Herkel J, Jagemann B, Wiegard C, Lazaro J. F, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology. 2003;37(5):1079-1085.

    Article  PubMed  CAS  Google Scholar 

  33. Houssin D, Gigou M, Franco D, Bismuth H, Charpentier B, Lang P, Martin E. Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation. 1980;29(5):418-419.

    Article  PubMed  CAS  Google Scholar 

  34. Issa N, Kukla A, Ibrahim HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am. J. Nephrol. 2013;37(6):602-612.

    Article  PubMed  CAS  Google Scholar 

  35. Jiang S, Lechler RI. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am. J. Transplant. 2003;3(5):516-524.

    Article  PubMed  CAS  Google Scholar 

  36. Karam VH, Gasquet I, Delvart V, Hiesse C, Dorent R, Danet C, Samuel D, Charpentier B, Gandjbakhch I, Bismuth H, Castaing D. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation. 2003;76(12):1699-1704.

    PubMed  Google Scholar 

  37. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM; Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299-311.

    Article  PubMed  Google Scholar 

  38. Khatri P, Roedder S, Kimura N, De Vusser K, Morgan AA, Gong Y, Fischbein MP, Robbins RC, Naesens M, Butte AJ, Sarwal MM. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J. Exp. Med. 2013;210(11):2205-2221.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Kholodenko IV, Yarygin KN. Cellular mechanisms of liver regeneration and cell-based therapies of liver diseases. Biomed. Res. Int. 2017;2017. ID 8910821. doi: https://doi.org/10.1155/2017/8910821.

  40. Kim SY, Kim DW, Choi JY, Kim DG, Min WS, Lee JW, Kim CC. Full donor chimerism using stem-cell transplantation for tolerance induction in the human leukocyte antigen-matched liver transplant setting. Transplantation. 2009;88(4):601-603.

    Article  PubMed  Google Scholar 

  41. Kingham TP, Chaudhry UI, Plitas G, Katz SC, Raab J, De-Matteo RP. Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion. Hepatology. 2007;45(2):445-454.

    Article  PubMed  CAS  Google Scholar 

  42. Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle PA, Hamann A, Crispe IN. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J. Immunol. 2002;169(5):2407-2413.

    Article  PubMed  CAS  Google Scholar 

  43. Knolle PA, Schmitt E, Jin S, Germann T, Duchmann R, Hegenbarth S, Gerken G, Lohse AW. Induction of cytokine production in naïve CD4+ T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology. 1999;116(6):1428-1440.

    Article  PubMed  CAS  Google Scholar 

  44. Lerut JP, Pinheiro RS, Lai Q, Stouffs V, Orlando G, Juri JM, Ciccarelli O, Sempoux C, Roggen FM, De Reyck C, Latinne D, Gianello P. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebocontrolled, randomized, investigator-driven study. Ann. Surg. 2014;260(5):886-891.

    Article  PubMed  Google Scholar 

  45. Li Y, Koshiba T, Yoshizawa A, Yonekawa Y, Masuda K, Ito A, Ueda M, Mori T, Kawamoto H, Tanaka Y, Sakaguchi S, Minato N, Wood KJ, Tanaka K. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am. J. Transplant. 2004;4(12):2118-2125.

    Article  PubMed  Google Scholar 

  46. Li Y, Lu L, Qian S, Fung JJ, Lin F. Hepatic stellate cells directly inhibit B cells via programmed death-ligand 1. J. Immunol. 2016;196(4):1617-1625.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, Momburg F, Arnold B, Knolle PA. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 2000;6(12):1348-1354.

    Article  PubMed  CAS  Google Scholar 

  48. Liu H, Bakthavatsalam R, Meng Z, Li Z, Li W, Perkins JD, Reyes J. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. Transplant. Proc. 2013;45(5):1853-1855.

    Article  PubMed  CAS  Google Scholar 

  49. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the longterm does not mirror the dramatic short-term success. Am. J. Transplant. 2011;11(6):1226-1235.

    Article  PubMed  CAS  Google Scholar 

  50. Lozano JJ, Pallier A, Martinez-Llordella M, Danger R, López M, Giral M, Londoño M. C, Rimola A, Soulillou JP, Brouard S, Sánchez-Fueyo A. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am. J. Transplant. 2011;11(9):1916-1926.

    Article  PubMed  CAS  Google Scholar 

  51. Marcén R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009;69(16):2227-2243.

    PubMed  Google Scholar 

  52. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J. Clin. Invest. 2008;118(8):2845-2857.

    PubMed  PubMed Central  Google Scholar 

  53. Martínez-Llordella M, Puig-Pey I, Orlando G, Ramoni M, Tisone G, Rimola A, Lerut J, Latinne D, Margarit C, Bilbao I, Brouard S, Hernández-Fuentes M, Soulillou JP, Sánchez-Fueyo A. Multiparameter immune profiling of operational tolerance in liver transplantation. Am. J. Transplant. 2007;7(2):309-319.

    Article  PubMed  CAS  Google Scholar 

  54. Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am. J. Transplant. 2003;3(6):689-696.

    Article  PubMed  Google Scholar 

  55. Nakafusa Y, Goss JA, Roland CR, Flye MW. The effect of portal venous tolerance on thesurvival of small bowel allografts in the rat. Transplantation. 1993;56(5):1279-1282.

    Article  PubMed  CAS  Google Scholar 

  56. Newell KA, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, Kanaparthi S, Asare S, Lim N, Stahly M, Howell M, Knechtle S, Kirk A, Marks WH, Kawai T, Spitzer T, Tolkoff-Rubin N, Sykes M, Sachs DH, Cosimi AB, Burlingham WJ, Phippard D, Turka LA. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am. J. Transplant. 2015;15(11):2908-2920.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. Noyan F, Zimmermann K, Hardtke-Wolenski M, Knoefel A, Schulde E, Geffers R, Hust M, Huehn J, Galla M, Morgan M, Jokuszies A, Manns MP, Jaeckel E. Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor. Am. J. Transplant. 2017;17(4):917-930.

    Article  PubMed  CAS  Google Scholar 

  58. Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J. Hepatol. 2009;50(6):1247-1257.

    Article  PubMed  Google Scholar 

  59. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP. Liver dendritic cells are less immuno-genic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 2004;172(2):1009-1017.

    Article  PubMed  CAS  Google Scholar 

  60. Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, Robles R, Rios A, Aparicio P, Parrilla P. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation. 2008;86(10):1370-1378.

    Article  PubMed  CAS  Google Scholar 

  61. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994;19(4):916-924.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity. 2009;30(5):656-665.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Riquelme P, Tomiuk S, Kammler A, Fändrich F, Schlitt HJ, Geissler EK, Hutchinson JA. IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. Mol. Ther. 2013;21(2):409-422.

    Article  PubMed  CAS  Google Scholar 

  64. Schliesser U, Chopra M, Beilhack A, Appelt C, Vogel S, Schumann J, Panov I, Vogt K, Schlickeiser S, Olek S, Wood K, Brandt C, Volk HD, Sawitzki B. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment. Eur. J. Immunol. 2013;43(12):3291-3305.

    Article  PubMed  CAS  Google Scholar 

  65. Schurich A, Berg M, Stabenow D, Böttcher J, Kern M, Schild HJ, Kurts C, Schuette V, Burgdorf S, Diehl L, Limmer A, Knolle PA. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J. Immunol. 2010;184(8):4107-4114.

    Article  PubMed  CAS  Google Scholar 

  66. Sellarés J, de Freitas D. G, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am. J. Transplant. 2012;12(2):388-399.

    Article  PubMed  Google Scholar 

  67. Shi M, Liu Z, Wang Y, Xu R, Sun Y, Zhang M, Yu X, Wang H, Meng L, Su H, Jin L, Wang FS. A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection. Stem Cells Transl. Med. 2017;6(12):2053-2061.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002;2(3):151-161.

    Article  PubMed  CAS  Google Scholar 

  69. Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, Gray EA, Eghtesad B, Shapiro R, Marcos A, Fung JJ. Lessons of organ induced tolerance learned from historical clinical experience. Transplantation. 2004;77(6):926-929.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Tay SS, Wong YC, McDonald DM, Wood NA, Roediger B, Sierro F, Mcguffog C, Alexander IE, Bishop GA, Gamble JR, Weninger W, McCaughan GW, Bertolino P, Bowen DG. Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses. Proc. Natl Acad. Sci. USA. 2014;111(25):E2540-E2549.

    Article  PubMed  CAS  Google Scholar 

  71. Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier J. C, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study. Transpl. Int. 2016;29(1):23-33.

    Article  PubMed  CAS  Google Scholar 

  72. Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, Watanabe M, Aoyagi T, Suzuki T, Shimamura T, Kamiyama T, Sato N, Sugita J, Hatanaka K, Bashuda H, Habu S, Demetris AJ, Okumura K. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology. 2016;64(2):632-643.

    Article  PubMed  CAS  Google Scholar 

  73. Tryphonopoulos P, Tzakis AG, Weppler D, Garcia-Morales R, Kato T, Madariaga JR, Levi DM, Nishida S, Moon J, Selvaggi G, Regev A, Nery C, Bejarano P, Khaled A, Kleiner G, Esquenazi V, Miller J, Ruiz P, Ricordi C. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am. J. Transplant. 2005;5(3):608-613.

    Article  PubMed  Google Scholar 

  74. Umeda K, Adachi S, Watanabe K, Kimura N, Lin Y, Nakahata T. Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation. Bone Marrow Transplant. 2002;30(8):531-534.

    Article  PubMed  CAS  Google Scholar 

  75. Vincenti F. Belatacept and long-term outcomes in kidney transplantation. N. Engl. J. Med. 2016;374(26):2600-2601.

    PubMed  Google Scholar 

  76. von Oppen N, Schurich A, Hegenbarth S, Stabenow D, Tolba R, Weiskirchen R, Geerts A, Kolanus W, Knolle P, Diehl L. Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology. 2009;49(5):1664-1672.

    Article  CAS  Google Scholar 

  77. Weiskirchen R, Tacke F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg. Nutr. 2014;3(6):344-363.

    PubMed  PubMed Central  Google Scholar 

  78. Whitehouse GP, Sanchez-Fueyo A. Immunosuppression withdrawal following liver transplantation. Clin. Res. Hepatol. Gastroenterol. 2014;38(6):676-680.

    Article  PubMed  Google Scholar 

  79. Wieërs G, Gras J, Bourdeaux C, Truong D. Q, Latinne D, Reding R. Monitoring tolerance after human liver transplantation. Transpl. Immunol. 2007;17(2):83-93.

    Article  PubMed  CAS  Google Scholar 

  80. Womer KL, Kaplan B. Recent developments in kidney transplantation — a critical assessment. Am. J. Transplant. 2009;9(6):1265-1271.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Xia S, Guo Z, Xu X, Yi H, Wang Q, Cao X. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood. 2008;112(8):3175-3185.

    PubMed  CAS  Google Scholar 

  82. Yang HR, Chou HS, Gu X, Wang L, Brown KE, Fung JJ, Lu L, Qian S. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology. 2009;50(6):1981-1991.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. You Q, Cheng L, Kedl R. M, Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. 2008;48(3):978-990.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ, Lu L, Qian S. Inhibition of T cell responses by hepatic stellate cells via B7-H1 mediated T cell apoptosis. Hepatology. 2004;40(6):1312-1321.

    Article  PubMed  CAS  Google Scholar 

  85. Zhou Z, Xu MJ, Gao B. Hepatocytes: a key cell type for innate immunity. Cell Mol. Immunol. 2016;13(3):301-315.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. V. Kholodenko.

Additional information

Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 2, pp. 97-107, June, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kholodenko, I.V., Kholodenko, R.V., Lupatov, A.Y. et al. Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation. Bull Exp Biol Med 165, 554–563 (2018). https://doi.org/10.1007/s10517-018-4213-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4213-8

Key Words

Navigation